This list is an analysis based on recent market events. It's not an investment recommendation.
About
Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Its therapeutic drug candidate is KIN001, an advanced clinical stage p38 MAPK inhibitor combined with a marketed drug together enabling an oral long-term treatment for patients suffering from diseases. The company is based in Lausanne, Switzerland.
The current price of CURN.SW is CHF22.5 CHF — it has increased by +4.17% in the past 24 hours. Watch Curatis stock price performance more closely on the chart.
What is Curatis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Curatis stocks are traded under the ticker CURN.SW.
Is Curatis stock price growing?▼
CURN.SW stock has risen by +5.14% compared to the previous week, the month change is a +27.84% rise, over the last year Curatis has showed a +105.48% increase.
What is Curatis revenue for the last year?▼
Curatis revenue for the last year amounts to 13.79M CHF.
What is Curatis net income for the last year?▼
CURN.SW net income for the last year is -8.69M CHF.
How many employees does Curatis have?▼
As of April 03, 2026, the company has 9 employees.
When did Curatis complete a stock split?▼
The last stock split for Curatis was on April 26, 2024 with a ratio of 1:4480.